Grossman Adam S's Form 4 filing
Adma Biologics, Inc.ADMA · filed Aug 27, 2024
- Accession no.
- 0001140361-24-038772
- Filed
- Aug 27, 2024
- Trade date
- Aug 26-27, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 7 derivative transactions. Open-market sales total $10.9M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grossman Adam SCIK 0001542517 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +64,405 | $3.35 | +$215,756.75 | 2,124,131 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +55,000 | $5.00 | +$275,000 | 2,179,131 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +16,984 | $5.96 | +$101,224.64 | 2,196,115 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +40,500 | $9.37 | +$379,485 | 2,236,615 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +60,000 | $10.80 | +$648,000 | 2,296,615 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −236,889 | $17.69F1 | −$4,190,566.41 | 2,059,726 | Direct | |
| Aug 27, 2024 | Common Stock | MOption exerciseAcquired | +341,960 | $3.35 | +$1,145,566 | 2,401,686 | Direct | |
| Aug 27, 2024 | Common Stock | MOption exerciseAcquired | +47,396 | $2.92 | +$138,396.32 | 2,449,082 | Direct | |
| Aug 27, 2024 | Common Stock | SSaleDisposed | −389,356 | $17.29F2 | −$6,731,965.24 | 2,059,726 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −64,405 | $3.35 | −$215,756.75 | 1,082,980 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −55,000 | $5.00 | −$275,000 | 0 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −16,984 | $5.96 | −$101,224.64 | 0 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −40,500 | $9.37 | −$379,485 | 0 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −60,000 | $10.80 | −$648,000 | 0 | Direct | |
| Aug 27, 2024 | Common Stock | MOption exerciseDisposed | −341,960 | $3.35 | −$1,145,566 | 741,020 | Direct | |
| Aug 27, 2024 | Common Stock | MOption exerciseDisposed | −47,396 | $2.92 | −$138,396.32 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $17.50 to $18.45. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $17.25 to $17.375. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.